ConductScience.org, home

Paper · 42840663

The Amyloid State of Mutant p53 in Cancer.

Iwahashi N and 1 other. JMA J, 2026.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. The Amyloid State of Mutant p53 in Cancer. Papers, record 42840663. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42840663

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The Amyloid State of Mutant p53 in Cancer.
Journal
JMA J
Year
2026
Publication types
Journal Article, Review
Revised in PubMed
2026-10-08

Source PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Iwahashi NNaoyuki
2Ino KKazuhiko

Source PubMed

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References63

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
115,261,674Exosomes: endosomal-derived vesicles shipping extracellular messages.Curr Opin Cell Biol2004https://conductscience.org/library/papers/15261674PubMed
238,212,344Amyloid aggregates induced by the p53-R280T mutation lead to loss of p53 function in nasopharyngeal carcinoma.Cell Death Dis2024https://conductscience.org/library/papers/38212344PubMed
339,031,627Impacts of cytoplasmic p53 aggregates on the prognosis and the transcriptome in lung squamous cell carcinoma.Cancer Sci2024https://conductscience.org/library/papers/39031627PubMed
419,345,189A Mutant-p53/Smad complex opposes p63 to empower TGFbeta-induced metastasis.Cell2009https://conductscience.org/library/papers/19345189PubMed
540,410,530Detection of p53 aggregates in plasma of glioma patients.Commun Med (Lond)2025https://conductscience.org/library/papers/40410530PubMed
622,869,710First-order rate-determining aggregation mechanism of p53 and its implications.Proc Natl Acad Sci U S A2012https://conductscience.org/library/papers/22869710PubMed
711,238,924A subset of tumor-derived mutant forms of p53 down-regulate p63 and p73 through a direct interaction with the p53 core domain.Mol Cell Biol2001https://conductscience.org/library/papers/11238924PubMed
840,657,305Long-term follow-up and combined Phase 2 results of eprenetapopt and azacitidine in patients with TP53 mutant MDS/AML.Hemasphere2025https://conductscience.org/library/papers/40657305PubMed
933,131,904Potential and mechanism of mebendazole for treatment and maintenance of ovarian cancer.Gynecol Oncol2021https://conductscience.org/library/papers/33131904PubMed
1036,471,402p53 immunostaining pattern is a useful surrogate marker for TP53 gene mutations.Diagn Pathol2022https://conductscience.org/library/papers/36471402PubMed

Cited by0

The papers in our copy of PubMed whose reference list names this one, newest first.

None in this release.

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42840663

GET https://conductscience.org/api/papers/v1/42840663/references?page=2